Tovorafenib Impurity 23 | CAS 122599-19-3 - Request Quote
Tovorafenib Impurity 23
| SZ CAT No: | SZ-T202031 |
| CAS No | 122599-19-3 |
| Mol.F. | C6Cl4F3N |
| Mol.Wt. | 284.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 23 is chemically 2,3,5,6-Tetrachloro-4-(trifluoromethyl)pyridine. Tovorafenib Impurity 23 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 23 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 122599-19-3
Purchase 122599-19-3
Order 122599-19-3
Enquire 122599-19-3
price of 122599-19-3
122599-19-3 Supplier
122599-19-3 Manufacturer
122599-19-3 Exporter
buy high quality Tovorafenib Impurity 23
Purchase Tovorafenib Impurity 23
Tovorafenib Impurity 23 suppliers
Tovorafenib Impurity 23 manufacturers
Tovorafenib Impurity 23 price
Order Tovorafenib Impurity 23
Enquire Tovorafenib Impurity 23
Tovorafenib Impurity 23 cost
Tovorafenib Impurity 23 Supplier
Tovorafenib Impurity 23 Distributor
Tovorafenib Impurity 23 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 23 for ANDA Filing
Tovorafenib Impurity 23 for Forced Degradation Studies
Tovorafenib Impurity 23 Identification Standards
Tovorafenib Impurity 23 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


